Correlation Between Salesforce and GeneReach Biotechnology
Can any of the company-specific risk be diversified away by investing in both Salesforce and GeneReach Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and GeneReach Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and GeneReach Biotechnology, you can compare the effects of market volatilities on Salesforce and GeneReach Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of GeneReach Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and GeneReach Biotechnology.
Diversification Opportunities for Salesforce and GeneReach Biotechnology
0.04 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Salesforce and GeneReach is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and GeneReach Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneReach Biotechnology and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with GeneReach Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneReach Biotechnology has no effect on the direction of Salesforce i.e., Salesforce and GeneReach Biotechnology go up and down completely randomly.
Pair Corralation between Salesforce and GeneReach Biotechnology
Considering the 90-day investment horizon Salesforce is expected to under-perform the GeneReach Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Salesforce is 1.01 times less risky than GeneReach Biotechnology. The stock trades about -0.3 of its potential returns per unit of risk. The GeneReach Biotechnology is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 2,705 in GeneReach Biotechnology on November 28, 2024 and sell it today you would earn a total of 100.00 from holding GeneReach Biotechnology or generate 3.7% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 77.27% |
| Values | Daily Returns |
Salesforce vs. GeneReach Biotechnology
Performance |
| Timeline |
| Salesforce |
| GeneReach Biotechnology |
Salesforce and GeneReach Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Salesforce and GeneReach Biotechnology
The main advantage of trading using opposite Salesforce and GeneReach Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, GeneReach Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneReach Biotechnology will offset losses from the drop in GeneReach Biotechnology's long position.| Salesforce vs. Zoom Video Communications | Salesforce vs. C3 Ai Inc | Salesforce vs. Shopify | Salesforce vs. Workday |
| GeneReach Biotechnology vs. Hua Nan Financial | GeneReach Biotechnology vs. Simplo Technology Co | GeneReach Biotechnology vs. Pontex Polyblend CoLtd | GeneReach Biotechnology vs. Kings Town Bank |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |